Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?
Inflammation, decreased levels of circulating endothelial nitric oxide (eNO) and brain-derived neurotrophic factor (BDNF), altered activity of hypothalamic neurotransmitters (including serotonin and vagal tone) and gut hormones, increased concentrations of free radicals, and imbalance in the levels...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fendo.2017.00182/full |
id |
doaj-584560976f4e49908433924feb694c35 |
---|---|
record_format |
Article |
spelling |
doaj-584560976f4e49908433924feb694c352020-11-24T22:57:23ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922017-08-01810.3389/fendo.2017.00182237579Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?Undurti N. Das0Undurti N. Das1BioScience Research Centre, Department of Medicine, Gayatri Vidya Parishad Hospital, GVP College of Engineering Campus, Visakhapatnam, IndiaUND Life Sciences, Battle Ground, WA, United StatesInflammation, decreased levels of circulating endothelial nitric oxide (eNO) and brain-derived neurotrophic factor (BDNF), altered activity of hypothalamic neurotransmitters (including serotonin and vagal tone) and gut hormones, increased concentrations of free radicals, and imbalance in the levels of bioactive lipids and their pro- and anti-inflammatory metabolites have been suggested to play a role in diabetes mellitus (DM). Type 1 diabetes mellitus (type 1 DM) is due to autoimmune destruction of pancreatic β cells because of enhanced production of IL-6 and tumor necrosis factor-α (TNF-α) and other pro-inflammatory cytokines released by immunocytes infiltrating the pancreas in response to unknown exogenous and endogenous toxin(s). On the other hand, type 2 DM is due to increased peripheral insulin resistance secondary to enhanced production of IL-6 and TNF-α in response to high-fat and/or calorie-rich diet (rich in saturated and trans fats). Type 2 DM is also associated with significant alterations in the production and action of hypothalamic neurotransmitters, eNO, BDNF, free radicals, gut hormones, and vagus nerve activity. Thus, type 1 DM is because of excess production of pro-inflammatory cytokines close to β cells, whereas type 2 DM is due to excess of pro-inflammatory cytokines in the systemic circulation. Hence, methods designed to suppress excess production of pro-inflammatory cytokines may form a new approach to prevent both type 1 and type 2 DM. Roux-en-Y gastric bypass and similar surgeries ameliorate type 2 DM, partly by restoring to normal: gut hormones, hypothalamic neurotransmitters, eNO, vagal activity, gut microbiota, bioactive lipids, BDNF production in the gut and hypothalamus, concentrations of cytokines and free radicals that results in resetting glucose-stimulated insulin production by pancreatic β cells. Our recent studies suggested that bioactive lipids, such as arachidonic acid, eicosapentaneoic acid, and docosahexaenoic acid (which are unsaturated fatty acids) and their anti-inflammatory metabolites: lipoxin A4, resolvins, protectins, and maresins, may have antidiabetic actions. These bioactive lipids have anti-inflammatory actions, enhance eNO, BDNF production, restore hypothalamic dysfunction, enhance vagal tone, modulate production and action of ghrelin, leptin and adiponectin, and influence gut microbiota that may explain their antidiabetic action. These pieces of evidence suggest that methods designed to selectively deliver bioactive lipids to pancreatic β cells, gut, liver, and muscle may prevent type 1 and type 2 DM.http://journal.frontiersin.org/article/10.3389/fendo.2017.00182/fullbioactive lipidsarachidonic acidlipoxin A4polyunsaturated fatty acidsresolvinsprotectins |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Undurti N. Das Undurti N. Das |
spellingShingle |
Undurti N. Das Undurti N. Das Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? Frontiers in Endocrinology bioactive lipids arachidonic acid lipoxin A4 polyunsaturated fatty acids resolvins protectins |
author_facet |
Undurti N. Das Undurti N. Das |
author_sort |
Undurti N. Das |
title |
Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? |
title_short |
Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? |
title_full |
Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? |
title_fullStr |
Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? |
title_full_unstemmed |
Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? |
title_sort |
is there a role for bioactive lipids in the pathobiology of diabetes mellitus? |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Endocrinology |
issn |
1664-2392 |
publishDate |
2017-08-01 |
description |
Inflammation, decreased levels of circulating endothelial nitric oxide (eNO) and brain-derived neurotrophic factor (BDNF), altered activity of hypothalamic neurotransmitters (including serotonin and vagal tone) and gut hormones, increased concentrations of free radicals, and imbalance in the levels of bioactive lipids and their pro- and anti-inflammatory metabolites have been suggested to play a role in diabetes mellitus (DM). Type 1 diabetes mellitus (type 1 DM) is due to autoimmune destruction of pancreatic β cells because of enhanced production of IL-6 and tumor necrosis factor-α (TNF-α) and other pro-inflammatory cytokines released by immunocytes infiltrating the pancreas in response to unknown exogenous and endogenous toxin(s). On the other hand, type 2 DM is due to increased peripheral insulin resistance secondary to enhanced production of IL-6 and TNF-α in response to high-fat and/or calorie-rich diet (rich in saturated and trans fats). Type 2 DM is also associated with significant alterations in the production and action of hypothalamic neurotransmitters, eNO, BDNF, free radicals, gut hormones, and vagus nerve activity. Thus, type 1 DM is because of excess production of pro-inflammatory cytokines close to β cells, whereas type 2 DM is due to excess of pro-inflammatory cytokines in the systemic circulation. Hence, methods designed to suppress excess production of pro-inflammatory cytokines may form a new approach to prevent both type 1 and type 2 DM. Roux-en-Y gastric bypass and similar surgeries ameliorate type 2 DM, partly by restoring to normal: gut hormones, hypothalamic neurotransmitters, eNO, vagal activity, gut microbiota, bioactive lipids, BDNF production in the gut and hypothalamus, concentrations of cytokines and free radicals that results in resetting glucose-stimulated insulin production by pancreatic β cells. Our recent studies suggested that bioactive lipids, such as arachidonic acid, eicosapentaneoic acid, and docosahexaenoic acid (which are unsaturated fatty acids) and their anti-inflammatory metabolites: lipoxin A4, resolvins, protectins, and maresins, may have antidiabetic actions. These bioactive lipids have anti-inflammatory actions, enhance eNO, BDNF production, restore hypothalamic dysfunction, enhance vagal tone, modulate production and action of ghrelin, leptin and adiponectin, and influence gut microbiota that may explain their antidiabetic action. These pieces of evidence suggest that methods designed to selectively deliver bioactive lipids to pancreatic β cells, gut, liver, and muscle may prevent type 1 and type 2 DM. |
topic |
bioactive lipids arachidonic acid lipoxin A4 polyunsaturated fatty acids resolvins protectins |
url |
http://journal.frontiersin.org/article/10.3389/fendo.2017.00182/full |
work_keys_str_mv |
AT undurtindas istherearoleforbioactivelipidsinthepathobiologyofdiabetesmellitus AT undurtindas istherearoleforbioactivelipidsinthepathobiologyofdiabetesmellitus |
_version_ |
1725650975858884608 |